Cyclo Therapeutics, Inc. ( CYTH) - Key Metrics
Stock symbol CYTH is outdated, potentially delisted? Maybe it is available on other exchange?
CYTH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.01 | -$0.31 | -$0.29 | -$0.42 |
| 2024Q2 | $0 | -$0.21 | -$0.13 | -$0.13 |
| 2024Q1 | $0.01 | -$0.15 | -$0.22 | -$0.22 |
| 2023Q4 | $0.01 | -$0.23 | -$0.17 | -$0.17 |
| 2023Q3 | $0.03 | -$0.29 | -$0.25 | -$0.25 |
CYTH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.64 |
| 2024Q2 | ? | -1.44 |
| 2024Q1 | ? | -2.24 |
| 2023Q4 | ? | -1.75 |
| 2023Q3 | ? | -1.20 |
CYTH
Price: $0.72
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 140400
Market Capitalization: 23.6 million